The smartphone-based pain assessment application has potential for use in children's hospitals, in postnatal wards, and among parents and other healthcare professionals.
This fortnight is the last chance for aged-care facilities to participate in the government-subsidised rollout of a complete point-of-care solution for best practice pain management.
The Avalon Study has demonstrated the life-changing benefits of a closed-loop spinal cord stimulation system in patients with chronic, intractable pain.
Patients with low back pain have been shown to respond well to NSAIDs such as ibuprofen, according to researchers at RMIT University.
ShotBlocker is a non-invasive solution that has been shown to reduce or remove pain in 93.2% of users at half the cost of topical freezing sprays and anaesthetic creams.
The product, pricing and patient analysis found that, over the last six months, intense medicinal cannabis product competition has kept downward pressure on prices.
University of Queensland pain researchers have made a discovery that could let future cancer patients avoid chemotherapy's worst and most debilitating side effects.
Applied Cannabis Research is conducting an observational study through CA Clinics, investigating medicinal cannabis for the treatment of endometriosis.
A NSW trial has led to a 24% reduction in opioid prescribing for patients with acute back pain in emergency departments.
The online Professional Diploma of Medicinal Cannabis aims to provide a best-practice roadmap for GPs on how to manage common conditions with medicinal cannabis.
Medicinal cannabis is any cannabis-based product prescribed to relieve the symptoms of a medical condition.
A tech partnership means that carers can now access a tool to help identify, monitor and reduce pain in dementia aged-care residents.
Molecules from the venom of one of the world's largest spiders could be used to develop pain blockers for people with irritable bowel syndrome.
Injuries sustained in a car accident left Mary in intense pain — she was eventually diagnosed with complex regional pain syndrome.
Australians suffering with chronic pain have reported a worsening in their relationship with their GP and pharmacist over the past two years, according to the National Pain Survey 2020.